Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) has been assigned a consensus rating of "Buy" from the six analysts that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating, two have given a buy rating and two have given a strong buy rating to the company.
A number of research firms have recently commented on STVN. TD Cowen raised shares of Stevanato Group to a "strong-buy" rating in a report on Wednesday, June 17th. Wolfe Research initiated coverage on shares of Stevanato Group in a research report on Tuesday, June 2nd. They set an "outperform" rating and a $21.00 price objective for the company. Finally, Weiss Ratings raised shares of Stevanato Group from a "hold (c-)" rating to a "hold (c)" rating in a research note on Thursday, August 27th.
Read Our Latest Stock Analysis on Stevanato Group
Stevanato Group Stock Down 0.4%
NYSE STVN opened at €20.45 on Friday. The business has a fifty day moving average price of €20.33 and a two-hundred day moving average price of €17.68. The stock has a market capitalization of $6.19 billion, a PE ratio of 36.52, a PEG ratio of 1.68 and a beta of 0.75. Stevanato Group has a fifty-two week low of €12.89 and a fifty-two week high of €28.00. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.61 and a quick ratio of 1.08.
Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing analysts' consensus estimates of €0.15 by (€0.01). Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%.The business had revenue of €302.00 million for the quarter. Equities analysts expect that Stevanato Group will post 0.71 earnings per share for the current fiscal year.
Insider Activity at Stevanato Group
In other news, Director Karen Flynn sold 1,493 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total value of €25,515.37. Following the completion of the transaction, the director directly owned 5,757 shares in the company, valued at approximately €98,387.13. This represents a 20.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director William Federici sold 1,493 shares of the firm's stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a total value of €25,515.37. Following the sale, the director directly owned 26,991 shares in the company, valued at approximately €461,276.19. This trade represents a 5.24% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 14,249 shares of company stock valued at $268,346. 0.70% of the stock is owned by company insiders.
Institutional Trading of Stevanato Group
Hedge funds have recently made changes to their positions in the company. Wellington Management Group LLP acquired a new position in shares of Stevanato Group in the second quarter valued at approximately $22,621,000. Ranger Investment Management L.P. bought a new stake in Stevanato Group during the 2nd quarter worth approximately $21,438,000. Conestoga Capital Advisors LLC increased its position in Stevanato Group by 7.6% in the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company's stock valued at $116,762,000 after acquiring an additional 602,050 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new position in shares of Stevanato Group during the fourth quarter valued at $9,269,000. Finally, Norges Bank bought a new position in shares of Stevanato Group during the fourth quarter valued at $8,185,000.
About Stevanato Group
(
Get Free Report)
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.